Glucotrack (GCTK) Other Non-Current Assets (2019 - 2025)
Glucotrack's (GCTK) quarterly Other Non-Current Assets came in at $10000.0 in Q1 2025, little changed YoY from $10000.0 in Q1 2024, and little changed on a QoQ basis from $10000.0 in Q4 2024.
Glucotrack (GCTK) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Glucotrack (GCTK) has 7 years of Other Non-Current Assets data on file, last reported at $10000.0 in Q1 2025.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $10000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $10000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $10000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $10000.0 in Q1 2025, from $10000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $78000.0 in Q2 2021 to a low of $9000.0 in Q3 2023.
- A 5-year average of $30176.5 and a median of $10000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 35.29% — and 2023, when it slumped 80.0%.
- Tracing GCTK's Other Non-Current Assets over 5 years: stood at $51000.0 in 2021, then tumbled by 62.75% to $19000.0 in 2022, then slumped by 47.37% to $10000.0 in 2023, then changed by 0.0% to $10000.0 in 2024, then changed by 0.0% to $10000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $10000.0 (Q1 2025), $10000.0 (Q4 2024), and $10000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 78,000.00 |
| Jun 30, 2021 | 78,000.00 |
| Mar 31, 2021 | 66,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Sep 30, 2020 | 57,653.00 |
| Dec 31, 2019 | 57,000.00 |